CMChristian Daniel Mutti

Christian Daniel Mutti

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Christian Daniel Mutti has a total of 20 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Development of the Mitochondrial Base Editor Analysis Package (MitoBEAP)

    by Christian D. Mutti, Pavel Nash, Pedro Silva-Pinheiro, Michal Minczuk, Lindsey Van Haute

    For many years, the genetic manipulation of mitochondrial DNA was largely hampered by inefficient delivery of nucleic acids to mitochondria. However, the development of mitoCBEs, such as mitochondrial cytosine base editors (DdCBEs), which catalyse C•G-to-T•A conversions, and more recently, mitoABEs, such as transcription-activator-like effector (TALE)-linked deaminases (TALEDs) enabling A•T-to-G•C conversion, has transformed this field. Generally, mitochondrial base editors exhibit high on-target efficiency and are straightforward to design and use. Nonetheless, unintended off-target effects cannot be overlooked and should be assessed consistently with each experiment, which can be challenging without specialised bioinformatic expertise. Here, we introduce Mitochondrial Base Editor Analysis Package (MitoBEAP), which, to our knowledge, is the first R package specifically designed to analyse next-generation sequencing data from base-edited mtDNA samples. The package facilitates the analysis of potential off-target effects, offers multiple visualisation options, and allows customisation of graphics and thresholds for calculations. As a proof of concept, this study demonstrates how MitoBEAP can be utilised to measure the efficiency of DdCBE treatment targeting human 12S rRNA, as well as to identify potentially harmful off-target conversions across the mtDNA.

  • Open Access

    Development of the Mitochondrial Base Editor Analysis Package (MitoBEAP)

    by Christian D. Mutti, Pavel Nash, Pedro Silva-Pinheiro, Michal Minczuk, Lindsey Van Haute

    For many years, the genetic manipulation of mitochondrial DNA was largely hampered by inefficient delivery of nucleic acids to mitochondria. However, the development of mitoCBEs, such as mitochondrial cytosine base editors (DdCBEs), which catalyse C•G-to-T•A conversions, and more recently, mitoABEs, such as transcription-activator-like effector (TALE)-linked deaminases (TALEDs) enabling A•T-to-G•C conversion, has transformed this field. Generally, mitochondrial base editors exhibit high on-target efficiency and are straightforward to design and use. Nonetheless, unintended off-target effects cannot be overlooked and should be assessed consistently with each experiment, which can be challenging without specialised bioinformatic expertise. Here, we introduce Mitochondrial Base Editor Analysis Package (MitoBEAP), which, to our knowledge, is the first R package specifically designed to analyse next-generation sequencing data from base-edited mtDNA samples. The package facilitates the analysis of potential off-target effects, offers multiple visualisation options, and allows customisation of graphics and thresholds for calculations. As a proof of concept, this study demonstrates how MitoBEAP can be utilised to measure the efficiency of DdCBE treatment targeting human 12S rRNA, as well as to identify potentially harmful off-target conversions across the mtDNA.


  • Open Access

    A library of base editors for the precise ablation of all protein-coding genes in the mouse mitochondrial genome

    by Pedro Silva-Pinheiro, Christian D. Mutti, Lindsey Van Haute, Christopher A. Powell, Pavel A. Nash, Keira Turner, Michal Minczuk

    The development of curative treatments for mitochondrial diseases, which are often caused by mutations in mitochondrial DNA (mtDNA) that impair energy metabolism and other aspects of cellular homoeostasis, is hindered by an incomplete understanding of the underlying biology and a scarcity of cellular and animal models. Here we report the design and application of a library of double-stranded-DNA deaminase-derived cytosine base editors optimized for the precise ablation of every mtDNA protein-coding gene in the mouse mitochondrial genome. We used the library, which we named MitoKO, to produce near-homoplasmic knockout cells in vitro and to generate a mouse knockout with high heteroplasmy levels and no off-target edits. MitoKO should facilitate systematic and comprehensive investigations of mtDNA-related pathways and their impact on organismal homoeostasis, and aid the generation of clinically meaningful in vivo models of mtDNA dysfunction.


  • Open Access

    In vivo mitochondrial base editing via adeno-associated viral delivery to mouse post-mitotic tissue

    by Pedro Silva-Pinheiro, Pavel A. Nash, Lindsey Van Haute, Christian D. Mutti, Keira Turner, Michal Minczuk

    Mitochondria host key metabolic processes vital for cellular energy provision and are central to cell fate decisions. They are subjected to unique genetic control by both nuclear DNA and their own multi-copy genome - mitochondrial DNA (mtDNA). Mutations in mtDNA often lead to clinically heterogeneous, maternally inherited diseases that display different organ-specific presentation at any stage of life. For a long time, genetic manipulation of mammalian mtDNA has posed a major challenge, impeding our ability to understand the basic mitochondrial biology and mechanisms underpinning mitochondrial disease. However, an important new tool for mtDNA mutagenesis has emerged recently, namely double-stranded DNA deaminase (DddA)-derived cytosine base editor (DdCBE). Here, we test this emerging tool for in vivo use, by delivering DdCBEs into mouse heart using adeno-associated virus (AAV) vectors and show that it can install desired mtDNA edits in adult and neonatal mice. This work provides proof-of-concept for use of DdCBEs to mutagenize mtDNA in vivo in post-mitotic tissues and provides crucial insights into potential translation to human somatic gene correction therapies to treat primary mitochondrial disease phenotypes.


  • Balancing of mitochondrial translation through METTL8-mediated m3C modification of mitochondrial tRNAs

    by Eva Schöller, James Marks, Virginie Marchand, Astrid Bruckmann, Christopher A. Powell, Markus Reichold, Christian Daniel Mutti, Katja Dettmer, Regina Feederle, Stefan Hüttelmaier, et al.